Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer

Androgens are a major driver of prostate cancer (PCa) and continue to be a critical treatment target for advanced disease, which includes castration therapy and antiandrogens. However, resistance to these therapies leading to metastatic castration-resistant prostate cancer (mCRPC), and the emergence...

Descripción completa

Detalles Bibliográficos
Autores principales: Peter, Madonna R., Bilenky, Misha, Davies, Alastair, Isserlin, Ruth, Bader, Gary D., Fleshner, Neil E., Hirst, Martin, Zoubeidi, Amina, Bapat, Bharati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988053/
https://www.ncbi.nlm.nih.gov/pubmed/33758253
http://dx.doi.org/10.1038/s41598-021-85812-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988053/
https://www.ncbi.nlm.nih.gov/pubmed/33758253
http://dx.doi.org/10.1038/s41598-021-85812-3

Ejemplares similares